Haleon (HLN) Treasury Shares (2024 - 2025)
Haleon (HLN) posted Treasury Shares of $62.5 million for Q4 2025, up 57.13% on a QoQ basis from $39.8 million in Q4 2024, and up 57.13% year-over-year from $39.8 million in Q4 2024.
Haleon (HLN) Treasury Shares (2024 - 2025) Analysis & Trends
Haleon's Treasury Shares history runs 2 years deep, the most recent figure standing at $62.5 million for Q4 2025.
- Quarterly Treasury Shares rose 57.13% year-over-year to $62.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $62.5 million (up 57.13% YoY) and the FY2025 annual result came in at $62.0 million, up 56.39% from the prior year.
- Treasury Shares was $62.5 million for Q4 2025 at Haleon, up from $39.8 million in the prior quarter.
- Across five years, Treasury Shares topped out at $62.5 million in Q4 2025 and bottomed at $39.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 62.52 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 107.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.29 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 313.27 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.44 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 59.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 62.52 Mn |
| Dec 31, 2025 | 62.52 Mn |
| Dec 31, 2024 | 39.79 Mn |
| Dec 31, 2024 | 39.79 Mn |